Ticker LaunchReverse merger · Completed · LENZ
LENZ Therapeutics (LENZ OpCo)
Reverse merger with Graphite Bio, Inc.
LENZ Therapeutics (LENZ OpCo) merged into Graphite Bio, Inc., a Nasdaq-listed biotech that wound down its programs before the merger, in a reverse merger that takes the private company public. It closed on Mar 21, 2024. The combined company trades as LENZ Therapeutics, Inc. (LENZ) on Nasdaq.
- Status
- Completed
- Private company
- LENZ Therapeutics (LENZ OpCo)
- Public company
- Graphite Bio, Inc.
- Public company business before
- Nasdaq-listed biotech that wound down its programs before the merger
- Closed
- Mar 21, 2024
- Combined company
- LENZ Therapeutics, Inc. (LENZ)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Mar 22, 2024
- Closing exhibit
- Announcement 8-K Oct 30, 2023
- All filings on EDGAR CIK 1815776
Other completed reverse mergers
- Trawsfynydd Therapeutics, Inc.into Onconova Therapeutics, Inc. · Apr 1, 2024
- VinHMS Pte. Ltd.into Vemanti Group, Inc. · Apr 1, 2024
- Serina Therapeutics, Inc.into AgeX Therapeutics, Inc. · Mar 26, 2024
- Q32 Bio Inc.into Homology Medicines, Inc. · Mar 25, 2024
- Emergent Health Corp.into Resonate Blends, Inc. · Mar 14, 2024
- XTI Aircraft Companyinto Inpixon · Mar 12, 2024